The revolution in microbiota research over the past decade has provided invaluable
knowledge about the function of the microbial species that inhabit the human body. It has …

Background While there seems to be a consensus that a decrease in gut microbiome
diversity is related to a decline in health status, the associations between respiratory …

Bronchiectasis is increasing in prevalence worldwide, yet current treatments available are
limited to those alleviating symptoms and reducing exacerbations. The pathogenesis of the …

Bronchiectasis is a heterogeneous chronic disease. Heterogeneity characterises
bronchiectasis not only in the stable state but also during exacerbations, despite evidence …

Introduction: Bronchiectasis is a chronic endobronchial suppurative disease characterized
by irreversibly dilated bronchi damaged by repeated polymicrobial infections and …

Objective To review the airway microbiome in chronic obstructive pulmonary disease
(COPD), bronchiectasis and bronchiectasis‐COPD overlap (BCO). Data source and study …

Bronchiectasis is marked by bronchial dilatation, recurrent infections and significant
morbidity, underpinned by a complex interplay between microbial dysbiosis and immune …

Antimicrobial therapies against cystic fibrosis (CF) lung infections are largely aimed at the
traditional, well-studied CF pathogens such as Pseudomonas aeruginosa and Burkholderia …

Gender differences in chronic respiratory disease, including cystic fibrosis and non-cystic
fibrosis bronchiectasis are clinically apparent and of increasing importance. Differences in …

Bronchiectasis exacerbation: a narrative review of causes, risk factors, management and
prevention - PMC Back to Top Skip to main content NIH NLM Logo Access keys NCBI …